waldenstrom's macroglobulinemia Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (1)
Phase 2 (2)

Interventional (3)

Dana-Farber Cancer Institute (1)
Institute of Hematology & Blood Diseases Hospital (1)
Memorial Sloan Kettering Cancer Center (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadwaldenstrom's macroglobulinemia

I am/have/hadlymphoma

I am/have/hadmeasurable disease

I am/have/hadcancer

I am/have/hadstem cell transplantation

I am/have/hadmonoclonal antibody therapy

I am/have/hadneutrophil count

I am/have/hadb-cell lymphoma

I am/have/hadabsolute neutrophil count

I am/have/hadneuropathy

I am/have/hadrecurrent disease

I am/have/hadamyloidosis

I am/have/hadfollicular lymphoma

I am/have/hadnight sweats

I am/have/hadcryoglobulinemia

I am/have/hadigm level

I am/have/hadfever

I am/have/hadcytopenia

I am/have/hadburkitt's lymphoma

I am/have/haddiffuse large b-cell lymphoma

added new label for I am/have/had

I am looking for

I am looking formonoclonal antibodies

I am looking formonoclonal protein

I am looking forfludarabine

I am looking foribrutinib

I am looking forcyclophosphamide

I am looking forlenalidomide

I am looking fordexamethasone

I am looking forconjugated bilirubin

I am looking fortositumomab

I am looking forgrowth factor

I am looking forixazomib

I am looking fordirect bilirubin

I am looking forchlorambucil

I am looking foranthracyclines

I am looking forbiologic agent

I am looking forzanubrutinib

I am looking foranthracycline

I am looking foridelalisib

I am looking forvenetoclax

I am looking forbiological factors

added new label for I am looking for

Advanced Filters

Found 240 clinical trials

None

None views

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Oncology
Recruiting

Zanubrutinib Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia

This study aims to evaluate the efficacy of BTK inhibitor Zanubrutinib combined with Ixazomib and Dexamethasone (ZID) for the newly diagnosed Waldenstrom Macroglobulinemia. This ZID regimen will be given up to 24 months and stopped for observation. We propose this combination will improve the deep remission (VGPR) compared to single …

cold agglutinin

cryoglobulinemia

neutrophil count

cyclophosphamide

treatment regimen

0 views
16 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Ibrutinib + Venetoclax in Untreated WM

This study evaluates the safety and efficacy of Ibrutinib combined with Venetoclax (IVEN) in the treatment of adults diagnosed with Waldenstrom's macroglobulinemia (WM) cancer with a specific MYD88 gene mutation. This research study involves an experimental drug combination of targeted therapies.

bone marrow biopsy

ibrutinib

absolute neutrophil count

growth factor

venetoclax

0 views
16 Feb, 2024
2 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

The purpose of this study is to test the safety of 19(T2)28z1xx CAR T cells in people with relapsed/refractory B-cell cancers. The researchers will try to find the highest dose of 19(T2)28z1xx CAR T cells that causes few or mild side effects in participants. Once they find this dose, they …

anthracycline

biologic agent

idelalisib

venetoclax

biological factors

0 views
05 Aug, 2020